"What we're seeing is the application of a solution to a
problem that, frankly, we don't have," said Gerry Harrington,
director of public affairs at the Non-Prescription Drug Manufacturers
Association of Canada.
"We don't believe there should be any retail restrictions
on these products."
Pharmacies have been struggling for several years to find a way
to deal with the problem. Manitoba and Saskatchewan have already
restricted the sales of some of the products to behind the counter.
The new rules apply to all drugs containing ephedrine and pseudoephedrine.
Annual sales of these drugs exceed $200-million in Canada.
Products that contain these elements as a single ingredient will
be sold only behind the counter at pharmacies.
Among the 17 products affected are Sudafed Decongestant 12-hour
caplets and non-drowsy Contac Cold 12-hour.
All cold, cough and allergy medications that contain multiple
ingredients including ephedrine and pseudoephedrine will be sold
only in pharmacies.
This category includes hundreds of products, such as big sellers
like Benylin, Tylenol Cold, Triaminic and Claritin Sinus.
Gary Sands, vice-president of the Canadian Federation of Independent
Grocers, said the decision to pull the products from only some
stores makes no sense. "If these products are really a problem,
then why not put them all behind the counter? I just don't understand
why you won't be able to buy cold and cough remedies in the grocery
store but you will be able to buy them off the shelf in the pharmacy."
Mr. Sands said while urban dwellers will simply have to shop
elsewhere for their cold and allergy medications, those in rural
and northern communities -- where pharmacies are harder to find
-- will be most affected by the new regulations.
Crystal meth -- which is also known as speed or crank -- can
be easily manufactured with a combination of fertilizer, cold
medication and sometimes products that contain ephedrine and are
sold in health food stores.
In Canada, most crystal meth is manufactured in large labs controlled
by biker gangs, who divert large quantities of the active ingredients
from drug companies.
In the United States, where commercial supplies have been choked
off, it is much more common to find home labs that make speed
in small quantities using cold and allergy medications bought
or stolen from retail stores.
Mr. Harrington said that only three dozen home meth labs were
found in Canada in the past five years. The number for the United
States in that period is 10,000.
"This is a knee-jerk response to an American problem,"
he said. But he said what was most concerning was the precedent
of NAPRA -- a group whose primary concern is supposed to be the
pharmacological safety of drugs -- wading into law enforcement
and losing sight of the fact that the vast majority of consumers
use these drugs responsibly and legitimately.
"Dealing with the serious problem of crystal meth requires
an understanding of criminal behaviour patterns and black market
economics, areas where this committee has no expertise,"
Mr. Harrington said.
Mr. Potvin of NAPRA acknowledged that this is "not the usual
application of our drug schedule," but said it was legitimate
for regulators to be concerned about the potential for drugs to
be abused and take counter measures.
He added that while home crystal meth labs may not be common
in Canada, regulators can and should be proactive. "This
is a preventive measure but it still allows the public broad access
to these very effective products," Mr. Potvin said.
sources :
http://www.theglobeandmail.com/servlet/story/RTGAM.20060118.wxcold18/BNStory/Nationall